Skip to main content
. Author manuscript; available in PMC: 2024 Sep 7.
Published in final edited form as: Bioorg Med Chem. 2023 Jun 29;92:117400. doi: 10.1016/j.bmc.2023.117400

Table 2.

Cytotoxicity against the MCF-7 Human Breast Cancer Cell Line

Compound IC50 (μM) SRB assay MCF-7a
OXi8006 b 0.048 ± 0.01
5a >5
5b 2.7 ± 0.2
5c 0.47 ± 0.02
5d >5
5e 3.7 ± 0.07
5f 1.7 ± 0.2
5g 4.8 ± 0.3
5h 0.78 ± 0.2
5i >5
5j >5
5k 0.84 ± 0.09
5l 3.2 ± 1.0
5m 1.6 ± 0.4
5n 2.2 ± 0.5
a

Average of n ≥ 3 independent determinations

b

See ref16 for additional OXi8006 data